DK166281C - Tetrahydroisoxazoloe4,5-caapyridin derivater og farmaceutisk acceptable syreadditionssalte deraf, farmaceutiske praeparater indeholdende disse forbindelser, og fremgangsmaade til deres fremstilling - Google Patents
Tetrahydroisoxazoloe4,5-caapyridin derivater og farmaceutisk acceptable syreadditionssalte deraf, farmaceutiske praeparater indeholdende disse forbindelser, og fremgangsmaade til deres fremstillingInfo
- Publication number
- DK166281C DK166281C DK240584A DK240584A DK166281C DK 166281 C DK166281 C DK 166281C DK 240584 A DK240584 A DK 240584A DK 240584 A DK240584 A DK 240584A DK 166281 C DK166281 C DK 166281C
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- alkyl
- acid addition
- addition salts
- acceptable acid
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 2
- 229960004373 acetylcholine Drugs 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 230000001270 agonistic effect Effects 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000007257 malfunction Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003222 pyridines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838314391A GB8314391D0 (en) | 1983-05-24 | 1983-05-24 | Heterocyclic compounds |
| GB8314391 | 1983-05-24 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK240584D0 DK240584D0 (da) | 1984-05-16 |
| DK240584A DK240584A (da) | 1984-11-25 |
| DK166281B DK166281B (da) | 1993-03-29 |
| DK166281C true DK166281C (da) | 1993-08-23 |
Family
ID=10543287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK240584A DK166281C (da) | 1983-05-24 | 1984-05-16 | Tetrahydroisoxazoloe4,5-caapyridin derivater og farmaceutisk acceptable syreadditionssalte deraf, farmaceutiske praeparater indeholdende disse forbindelser, og fremgangsmaade til deres fremstilling |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4608378A (da) |
| EP (1) | EP0126654B1 (da) |
| JP (1) | JPS6041680A (da) |
| AT (1) | ATE33984T1 (da) |
| CA (1) | CA1247105A (da) |
| DE (1) | DE3470883D1 (da) |
| DK (1) | DK166281C (da) |
| FI (1) | FI76805C (da) |
| GB (1) | GB8314391D0 (da) |
| IE (1) | IE57548B1 (da) |
| NO (1) | NO167147C (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| GB8727385D0 (en) * | 1987-11-23 | 1987-12-23 | Lundbeck & Co As H | Heterocyclic compounds |
| IL89351A0 (en) * | 1988-03-14 | 1989-09-10 | Lundbeck & Co As H | 4,5,6,7-tetrahydroisothiazolo(4,5-c)pyridines,process for their preparation and pharmaceutical compositions containing them |
| US4859666A (en) * | 1988-07-06 | 1989-08-22 | Bristol-Myers Company | THAZ derivatives for enhancement of cerebral function |
| GB8830226D0 (en) * | 1988-12-23 | 1989-02-22 | Beecham Group Plc | Novel compounds |
| US4920117A (en) * | 1989-06-09 | 1990-04-24 | Hoechst-Roussel Pharmaceuticals Inc. | 4,5,5a,6-tetrahydro-3H-isoxazolo(5,4,3-kl)acridines, pharmaceutical compositions and use |
| GB0328295D0 (en) * | 2003-12-05 | 2004-01-07 | Muscagen Ltd | Therapeutic compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK270278A (da) * | 1977-06-20 | 1978-12-21 | Krogsgaard Larsen P | Cycliske aminosyrer |
-
1983
- 1983-05-24 GB GB838314391A patent/GB8314391D0/en active Pending
-
1984
- 1984-05-14 IE IE1191/84A patent/IE57548B1/en not_active IP Right Cessation
- 1984-05-16 DK DK240584A patent/DK166281C/da active
- 1984-05-18 US US06/611,697 patent/US4608378A/en not_active Expired - Fee Related
- 1984-05-23 AT AT84303500T patent/ATE33984T1/de not_active IP Right Cessation
- 1984-05-23 EP EP84303500A patent/EP0126654B1/en not_active Expired
- 1984-05-23 CA CA000454969A patent/CA1247105A/en not_active Expired
- 1984-05-23 NO NO842064A patent/NO167147C/no unknown
- 1984-05-23 DE DE8484303500T patent/DE3470883D1/de not_active Expired
- 1984-05-24 FI FI842081A patent/FI76805C/fi not_active IP Right Cessation
- 1984-05-24 JP JP59103775A patent/JPS6041680A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6041680A (ja) | 1985-03-05 |
| FI842081A0 (fi) | 1984-05-24 |
| DE3470883D1 (en) | 1988-06-09 |
| NO167147C (no) | 1991-10-09 |
| EP0126654B1 (en) | 1988-05-04 |
| EP0126654A1 (en) | 1984-11-28 |
| IE57548B1 (en) | 1992-11-04 |
| NO167147B (no) | 1991-07-01 |
| ATE33984T1 (de) | 1988-05-15 |
| DK166281B (da) | 1993-03-29 |
| IE841191L (en) | 1984-11-24 |
| GB8314391D0 (en) | 1983-06-29 |
| CA1247105A (en) | 1988-12-20 |
| FI842081A7 (fi) | 1984-11-25 |
| DK240584A (da) | 1984-11-25 |
| NO842064L (no) | 1984-11-26 |
| DK240584D0 (da) | 1984-05-16 |
| FI76805B (fi) | 1988-08-31 |
| FI76805C (fi) | 1988-12-12 |
| JPH0585557B2 (da) | 1993-12-07 |
| US4608378A (en) | 1986-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113039A (pt) | Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto | |
| DK162519C (da) | Dihydropyridazinonderivater og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende forbindelserne | |
| LU90192I2 (fr) | Desirudine et ses sels et dérivés pharmaceutiquement acceptables (revasc) | |
| DK92781A (da) | Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf | |
| BR9910849A (pt) | Composto, processo para a profilaxia ou tratamento de uma condição clìnica em um mamìfero, tal como um humano, formulação farmacêutica, uso de um composto, processo para preparação do composto, e, derivado protegido. | |
| EP1228072A4 (en) | PDGF RECEPTOR KINASE INHIBITING COMPOUNDS, THEIR PRODUCTION, CLEANING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
| ES524680A0 (es) | Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina. | |
| DK166281C (da) | Tetrahydroisoxazoloe4,5-caapyridin derivater og farmaceutisk acceptable syreadditionssalte deraf, farmaceutiske praeparater indeholdende disse forbindelser, og fremgangsmaade til deres fremstilling | |
| ATE81130T1 (de) | 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridinderivate und isomere. | |
| FR2618436B1 (fr) | Derives de piperidine, leur preparation et leur application en therapeutique | |
| ATE34739T1 (de) | Neue 2-pyridin-thiol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| EP0318166A3 (en) | Isoxazolo[4,5-c]azepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| DE3889532D1 (de) | Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie. | |
| DK210387D0 (da) | Heterocykliske forbindelser og fremgangsmaade til deres fremstilling samt farmaceutiske midler indeholdende disse | |
| DK368984D0 (da) | 3-aryl-3-pyrrolidinderivater, fremgangsmaade til deres fremstilling samt anvendelse heraf til bekaempelse af hjerte- og karsygdomme | |
| TH2131B (th) | การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้ |